BioInnovatise Launches Plasmid DNA Library Construction Service to Accelerate Therapeutic Discovery
June 2, 2025
Rockville, MD — BioInnovatise is pleased to announce the expansion of its molecular biology service portfolio with the launch of its Plasmid Library Construction Service, supporting drug discovery, target screening, and early-stage development in gene therapy, oncology, and immunotherapy research. This offering reinforces BioInnovatise’s commitment to delivering high-precision DNA cloning solutions for advanced cell and gene therapy applications.
Unlock precise genome editing with our comprehensive CRISPR-Cas9 services. Our specialized sgRNA Cloning service ensures optimal targeting efficiency for gene editing projects, creating guide RNAs with exceptional specificity and functionality. This service seamlessly integrates with our CRISPR vector production, CRISPR cassette production and donor vector construction design, and CRISPR knock-in and knock-out services, offering a complete genome editing toolkit.